| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/20/2004 | US6723372 Spraying grains which consist of a prostane derivative and a cyclodextrin vehicle, forming together a prostane-cyclodextrine-clathrate, with an aqueous polymer dispersion of ethyl cellulose and/or poly(methyl)acrylic acid ester |
| 04/20/2004 | US6723358 Encapsulation of components into edible products |
| 04/20/2004 | US6723353 Preserved cyclodextrin-containing compositions |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723348 Orodispersible tablets containing fexofenadine |
| 04/20/2004 | US6723345 Topical drug preparations |
| 04/20/2004 | US6723344 Useful as implantable devices and wound dressings as the matrix of the invention is designed to be used in conjunction with such devices to provide protracted and controlled release of growth factor, to promote wound healing |
| 04/20/2004 | US6723343 Pharmaceutical tramadol salts |
| 04/20/2004 | US6723342 Edible coating composition |
| 04/20/2004 | US6723340 Optimal polymer mixtures for gastric retentive tablets |
| 04/20/2004 | US6723339 Hard gelatine capsule |
| 04/20/2004 | US6723337 Non-aqueous acrylic polymer, superior adhesion and durability instead of water-soluble polymer significantly decreases thickness of patch; non-ionic surfactant and terpene are used as absorption enhancers; dissolution assistant is used |
| 04/20/2004 | US6723326 Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
| 04/20/2004 | US6723320 Using monoclonal antibodies; polymerase chain reactions |
| 04/20/2004 | US6723318 Targeting of biomolecules |
| 04/20/2004 | US6723229 From mineral oil distillates; hydrotreatment; hydrogenation/ hydrodesulfurization; producing a product stream which is low in aromatics and which has substantially ?nil? sulfur; and selective hydrogenation |
| 04/20/2004 | CA2247405C Slow-release pharmaceutical formulations containing mizolastin |
| 04/20/2004 | CA2192725C Camptothecin derivatives |
| 04/20/2004 | CA2125408C Drug formulations for parenteral use |
| 04/20/2004 | CA2102778C Novel compositions based on taxane class derivatives |
| 04/20/2004 | CA2054822C Formulations and their use in the treatment of neurological diseases |
| 04/20/2004 | CA2044593C Method of in vivo delivery of functioning foreign genes |
| 04/17/2004 | CA2444781A1 Topical gel matrix |
| 04/15/2004 | WO2004031379A1 Proteins having polysaccharidase activity |
| 04/15/2004 | WO2004031221A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031220A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031214A1 Fine spherical particles with satisfactory molecular orientation, spherical microcapsules comprising the same, and processes for producing these |
| 04/15/2004 | WO2004030701A1 Conjugated hydroxyalkyl starch allergen compounds |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030687A1 Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
| 04/15/2004 | WO2004030667A1 Nasal drop composition |
| 04/15/2004 | WO2004030665A1 Transparent gel composition, for the administration of diclofenac sodium through the skin |
| 04/15/2004 | WO2004030661A2 Therapeutic compositions comprising a boron-containing compound |
| 04/15/2004 | WO2004030650A2 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 04/15/2004 | WO2004030623A2 Nitroxide radioprotector formulations and methods of use |
| 04/15/2004 | WO2004030617A2 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 04/15/2004 | WO2004030610A2 Compositions and methods for the intracellular delivery of antibodies |
| 04/15/2004 | WO2004022630A3 Water-soluble polymer alkanals |
| 04/15/2004 | WO2004019991A3 Scatter factor/hepatocyte growth factor antagonist nk4 for the treatment of glioma |
| 04/15/2004 | WO2004017962A3 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 04/15/2004 | WO2004009774A3 Protein conjugates with a water-soluble biocompatible, biogradable polymer |
| 04/15/2004 | WO2004004689A8 Compositions and methods for amelioration of human female sexual dysfunction |
| 04/15/2004 | WO2004002398A3 Spherical pellet containing a water-soluble active ingredient |
| 04/15/2004 | WO2003088956A8 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide |
| 04/15/2004 | WO2003086471A3 Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin |
| 04/15/2004 | WO2003077888A3 Compressed tablets comprising microcapsules with modified release |
| 04/15/2004 | WO2003066064A3 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics |
| 04/15/2004 | WO2003054543A3 Probe for mass spectrometry |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2002055721A3 Modular transfection systems based on nucleoprotein filaments |
| 04/15/2004 | WO2002016553B1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 04/15/2004 | WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 04/15/2004 | US20040073964 Using washing media containing polysaccharide containing arabinose, galactose and fatty acid units; activation ; storage; prevent cellular damage |
| 04/15/2004 | US20040073296 Inhibition of restenosis using a DNA-coated stent |
| 04/15/2004 | US20040072986 Ring opening polymerization of lactide, glycolide in presence of dextran sulfate in an extruder; sustained release; drug delivery |
| 04/15/2004 | US20040072961 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 04/15/2004 | US20040072911 Mixture of antiseptic, bactericide and lubricant |
| 04/15/2004 | US20040072909 Veterinary compositions for the treatment of parasitic diseases |
| 04/15/2004 | US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 04/15/2004 | US20040072810 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| 04/15/2004 | US20040072799 Drug delivery; mixture of cyclodextrin and amphiphilic copolymer |
| 04/15/2004 | US20040072798 Compositions comprising cyclodextrins and no-releasing drugs |
| 04/15/2004 | US20040072797 In liquid siolvent; parenterally administering; aldosterone receptors blockers; congestive heart failure, hypotensive agents, liver disorders |
| 04/15/2004 | US20040072795 Complex of Dna and lipid with detectable label; accuracy positioning; anticancer agents, antiinflammatory agents |
| 04/15/2004 | US20040072793 Amide derivatives; scaffold for tissue regeneration; drug delivery biodegradable; tissue adhesive |
| 04/15/2004 | US20040072792 Local anesthetic and agent for maintaining anesthetic action; acidic mucopolysaccharide or a cellulose derivative; does not contain a catecholamine; for oral surgery or dental treatment; sodium chondroitin sulfate; hydroxypropylmethylcellulose |
| 04/15/2004 | US20040072785 Ischemia; polynucleotide for transfection; polynucleotide is inserted into an artery or a vein; prior to injection the volume of the muscle tissue is increased such that the genetic material is delivered to the parenchymal cell |
| 04/15/2004 | US20040072784 Micelles formed from amphiphilic polymers associate or dissociate reversibly upon ph changes; oral or parenteral delivery of hydrophobic or cationic pharmaceutical; copolymer of polyethylene oxide and polyacrylic acid-butyl acrylate |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072766 Bioassay for screening an inhibitor or activator of phosphatidylinositol 3-kinase, finding immunostimulants, or immunosuppressants |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072755 A fusion proteins, a binding proteins as anticarcinogenic agents for treating cancer, antiinflammatory agents, treating atherosclerosis and ischemia/ reperfusion |
| 04/15/2004 | US20040072743 Pharmaceutical composition of modified pna molecules |
| 04/15/2004 | US20040072735 Administering suberoylanilide hydroxamic acid (SAHA) to inhibit histone deacetylase (HDAC) to a patient for cancer cell growth arrest and/or apoptosis of neoplastic cells |
| 04/15/2004 | US20040072729 Administering PEG-hemoglobin (polyethylene glycol-conjugated hemoglobin) solution with specific ability to deliver oxygen to cells of a mammal under ischemia or hypoxia |
| 04/15/2004 | US20040072726 Decoy is an NF- kappa B decoy, an ets decoy, or a chimera decoy of NF- kappa B and ets. The disease is cerebral aneurysm, cancer, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic etc. |
| 04/15/2004 | US20040072340 Use of peptide vectors to improve the immune response to antigens |
| 04/15/2004 | US20040072291 Comprises genetically engineered nerve growth factor for diagnosis and treatment of nervous system and neurodegenerative disease |
| 04/15/2004 | US20040072222 A conformational model of linear epitope sequence from guinea pig MBP72-85 and human MBP87-99 |
| 04/15/2004 | US20040072219 Genetically engineered obesity protein with reduced immune response for treatment of diabetes, high blood pressure and cholesterol metabolism disorders |
| 04/15/2004 | US20040071784 Composite material and process for increasing bioavailability and activity of a beneficial agent |
| 04/15/2004 | US20040071782 Ionophore antibiotic formulations |
| 04/15/2004 | US20040071779 Gelled laxative compositions |
| 04/15/2004 | US20040071778 Gel administered as drops or ointment with free-flowing vehicle and benzyllauryldimethylammonium chloride preservative |
| 04/15/2004 | US20040071777 In hydrophilic cellulose ether, polyvinyl pyrrolidone, or polyethylene glycol; amorphous |
| 04/15/2004 | US20040071775 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 04/15/2004 | US20040071774 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 04/15/2004 | US20040071771 Fenofibrate-containing composition |
| 04/15/2004 | US20040071769 Buffer, surfactant, chelate compound, nonionic preservative microbiocide; sensitivity; wound healing agents; topical, drug delivery |
| 04/15/2004 | US20040071767 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 04/15/2004 | US20040071765 Electrconductive layer containing basic and/or acidic water swelling methacrylate copolymer; transdermal drug delivery |
| 04/15/2004 | US20040071764 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 04/15/2004 | US20040071763 Composition for use in electroporation |
| 04/15/2004 | US20040071755 Water soluble sheet composition |
| 04/15/2004 | US20040071753 Enhancement of development of oviparous species by in ovo feeding of enteric modulators |
| 04/15/2004 | US20040071748 Stable hydroalcoholic compositions |
| 04/15/2004 | US20040071736 Topicalyl administering light chain fragment of clostridial neurotoxin including active proteolytic enzyme domain; chronic obstructive pulmonary disease (COPD) treatment; antiasthmatics and antisecretory agents |
| 04/15/2004 | US20040071735 Bone and muscular disorder treatment |
| 04/15/2004 | US20040071734 Novel vaccine |